Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.1M
-
Number of holders
-
256
-
Total 13F shares, excl. options
-
44.1M
-
Shares change
-
-968K
-
Total reported value, excl. options
-
$1.93B
-
Value change
-
-$43.5M
-
Number of buys
-
92
-
Number of sells
-
-100
-
Price
-
$43.74
Significant Holders of AVANOS MEDICAL, INC. - Common Stock (AVNS) as of Q1 2021
287 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock as of Q1 2021.
AVANOS MEDICAL, INC. - Common Stock (AVNS) has 256 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.1M shares
of 46.1M outstanding shares and own 95.55% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.61M shares), VANGUARD GROUP INC (4.48M shares), WELLINGTON MANAGEMENT GROUP LLP (3.94M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.22M shares), Champlain Investment Partners, LLC (2.91M shares), Paradice Investment Management LLC (2.47M shares), DIMENSIONAL FUND ADVISORS LP (2.27M shares), VICTORY CAPITAL MANAGEMENT INC (1.95M shares), RGM Capital, LLC (1.92M shares), and STATE STREET CORP (1.69M shares).
This table shows the top 256 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.